EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking

Ming-Yang Liu iD, Dong-Xin Jiang, Xiang Zhao, Liang Zhang, Yu Zhang, Zhen-Dong Liu, Run-Ze Liu, Hai-Jun Li, Xiao-Yu Rong, Yan-Zheng Gao iD

Orthopaedic Surgery · 2024

DOI: 10.1111/os.13971 ↗

At a glance

Journal article in Orthopaedic Surgery, 2024. Written by Ming-Yang Liu and 9 co-authors. Institution: Henan Province Intelligent Orthopedic Technology Innovation and Transformation International Joint Laboratory, Henan Key Laboratory for Intelligent P…. Major MEDLINE topics: Ginsenosides, Osteosarcoma, Bone Neoplasms, Drugs, Chinese Herbal. Cited 6 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Henan Provincial Medical Science and Technology Tackling Program Provincial-Ministerial Co-construction Project, Henan Postdoctoral Fund.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Osteosarcoma is a primary malignancy originating from mesenchymal tissue characterized by rapid growth, early metastasis and poor prognosis. Ginsenoside Rg5 (G‐Rg5) is a minor ginsenoside extracted from Panax ginseng C.A. Meyer which has been discovered to possess anti‐tumor properties. The objective of current study was to explore the mechanism of G‐Rg5 in the treatment of osteosarcoma by network pharmacology and molecular docking technology.

Methods

Pharmmapper, SwissTargetPrediction and similarity ensemble approach databases were used to obtain the pharmacological targets of G‐Rg5. Related genes of osteosarcoma were searched for in the GeneCards, OMIM and DrugBank databases. The targets of G‐Rg5 and the related genes of osteosarcoma were intersected to obtain the potential target genes of G‐Rg5 in the treatment of osteosarccoma. The STRING database and Cytoscape 3.8.2 software were used to construct the protein–protein interaction (PPI) network, and the Database for Annotation, Visualization and Integrated Discovery (DAVID) platform was used to perform gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. AutoDock vina software was used to perform molecular docking between G‐Rg5 and hub targets. The hub genes were imported into the Kaplan–Meier Plotter online database for survival analysis.

Results

A total of 61 overlapping targets were obtained. The related signaling pathways mainly included PI3K‐Akt signaling pathway, Proteoglycans in cancer, Lipid and atherosclerosis and Kaposi sarcoma‐associated herpesvirus infection. Six hub targets including PIK3CA, SRC, TP53, MAPK1, EGFR, and VEGFA were obtained through PPI network and targets‐pathways network analyses. The results of molecular docking showed that the binding energies were all less than –7 kcal/mol. And the results of survival analysis showed TP53 and VEGFA affect the prognosis of sarcoma patients.

Conclusion

This study explored the possible mechanism of G‐Rg5 in the treatment of osteosarcoma using network pharmacology method, suggesting that G‐Rg5 has the characteristics of multi‐targets and multi‐pathways in the treatment of osteosarcoma, which lays a foundation for the follow‐up experimental and clinical researches on the therapeutic effects of G‐Rg5 on osteosarcoma.

Subjects

MeSH terms (MEDLINE)

GinsenosidesOsteosarcomaBone NeoplasmsDrugs, Chinese HerbalHumansMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-Kinases

Author keywords

Ginsenoside Rg5Molecular dockingNetwork pharmacologyOsteosarcomaSurvival analysis

Substances

ginsenoside Rg5GinsenosidesPhosphatidylinositol 3-KinasesDrugs, Chinese Herbal

Authors and institutions

  • Henan Province Intelligent Orthopedic Technology Innovation and Transformation International Joint Laboratory, Henan Key Laboratory for Intelligent Precision Orthopedics, Department of Surgery of Spine and Spinal Cord,…
  • Department of Immunity, Institute of Translational Medicine, The First Hospital of Jilin University, Jilin, China.

ORCID profiles: Ming-Yang Liu, Yan-Zheng Gao

Funding

  • Henan Provincial Medical Science and Technology Tackling Program Provincial-Ministerial Co-construction Project
  • Henan Postdoctoral Fund

Cite

APA

Liu, M. Y., Jiang, D. X., Zhao, X., Zhang, L., Zhang, Y., Liu, Z. D., Liu, R. Z., Li, H. J., Rong, X. Y., & Gao, Y. Z. (2024). Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking. Orthopaedic Surgery. https://doi.org/10.1111/os.13971

Vancouver

Liu MY, Jiang DX, Zhao X, Zhang L, Zhang Y, Liu ZD, et al. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking. Orthopaedic Surgery. 2024. doi:10.1111/os.13971

BibTeX
@article{Liu2024,
  author = {Liu, Ming-Yang and Jiang, Dong-Xin and Zhao, Xiang and Zhang, Liang and Zhang, Yu and Liu, Zhen-Dong and Liu, Run-Ze and Li, Hai-Jun and Rong, Xiao-Yu and Gao, Yan-Zheng},
  title = {Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking},
  journal = {Orthopaedic Surgery},
  year = {2024},
  doi = {10.1111/os.13971}
}
Start for free →